Adding cystatin C to serum creatinine testing better-identified patients at risk for end-stage kidney disease and all-cause death, new study findings indicate. “Our results suggest that a ...
Neoadjuvant chemotherapy (NAC) is the standard of care for many triple-negative breast cancer (TNBC patients), who lack estrogen and progesterone receptors as well as the HER2 receptor. Although NAC ...
A recent study from Necmettin Erbakan University has identified a protein called CRELD2 as a possible biomarker for predicting survival in patients with triple-negative breast cancer (TNBC)—one of the ...
Cancer biology is influenced by the tumor microenvironment, which impacts disease prognosis and therapeutic interventions. The inter-relationship of tumor-infiltrating lymphocytes, immune response ...
Second-trimester screening of a pregnant woman's serum for markers of such congenital abnormalities as fetal trisomy 21 (Down syndrome) and neural tube defects has become an important part of ...
Physicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery treatment known as AC chemotherapy, ...
A new diagnostic strategy that includes three markers may significantly improve the detection and treatment of kidney disease, according to findings published online in the Journal of the American ...
Retrospective cost analysis of breast cancer patients treated in a Brazilian outpatient cancer center (OCC). Background: In general approximately 10%-15% of breast carcinomas (BCs) are known to be ...
Effect of gamma-radiation on healthy rat liver and gene expression of chemokines: In vivo and in vitro studies. Background: Breast carcinomas lacking expression of ER, PR, and HER2 (triple-negative ...
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC also is more likely to metastasize, or travel through the blood stream ...
Results of triple marker testing are usually reported as both actual concentration and MoM values, and an individual risk assessment is provided. An MoM is defined as the ratio of an individual marker ...